Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML Nanotech Investing
State Street to Expand Latin America Footprint with Santander CACEIS Latam Securities Services Fintech Investing
BlackRock® Canada Announces Final July Cash Distributions for the iShares® Premium Money Market ETF Fintech Investing
Cybeats Technologies Corp. Closes Oversubscribed $1.9M Non-Brokered Private Placement Technology Investing
Montauk Renewables Schedules Second Quarter 2026 Conference Call for Thursday, August 6, 2026, at 8:30 a.m. ET Cleantech Investing
